Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNNI3K | Q59H18 | 3/20 | 0.54 |
| ▸ | EGFR | P00533 | 9/20 | 0.52 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.52 |
| ▸ | KARS1 | Q15046 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.48 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ABL1 | P00519 | 1/20 | 0.46 |
| ▸ | ABL2 | P42684 | 1/20 | 0.46 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18772775 | 0.86 | TNNI3K (0.59) | TNNI3KEGFRKARS1NPSR1KMT2A | |
| SCHEMBL690632 | 0.83 | EGFR (0.62) | TNNI3KEGFRERBB2KMT2AABL1 | |
| SCHEMBL30216764 | 0.81 | KCNH2 (0.58) | EGFRKCNH2SCN5ASCN9AKMT2A | |
| SCHEMBL23588551 | 0.81 | KCNH2 (0.58) | EGFRKCNH2SCN5ASCN9AKMT2A | |
| SCHEMBL13166084 | 0.80 | TNNI3K (0.63) | TNNI3KEGFRABL1RAB9A | |
| SCHEMBL29645155 | 0.79 | ROCK1 (0.68) | TNNI3KEGFR | |
| SCHEMBL8798667 | 0.79 | EGFR (0.61) | TNNI3KEGFRERBB2NPSR1ABL1 | |
| SCHEMBL6837492 | 0.78 | RAB9A (0.63) | TNNI3KEGFRNPSR1KMT2AGRM4 | |
| SCHEMBL1387302 | 0.78 | EGFR (0.72) | TNNI3KEGFRERBB2NPSR1KMT2A | |
| SCHEMBL5575226 | 0.77 | MAPT (0.67) | EGFRERBB2NPSR1KMT2AABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107922387-A | HETEROCYCLIC INHIBITORS OF ERK1 AND ERK2 AND THEIR USE IN THE TREATMENT OF CANCER | 阿沙纳生物科学公司 | 2018-04-17 | — | — | CN | disclosed |